1
|
Amar Y, Rogner D, Silva RL, Foesel BU, Ud-Dean M, Lagkouvardos I, Steimle-Grauer SA, Niedermeier S, Kublik S, Jargosch M, Heinig M, Thomas J, Eyerich S, Wikström JD, Schloter M, Eyerich K, Biedermann T, Köberle M. Darier's disease exhibits a unique cutaneous microbial dysbiosis associated with inflammation and body malodour. MICROBIOME 2023; 11:162. [PMID: 37496039 PMCID: PMC10369845 DOI: 10.1186/s40168-023-01587-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/16/2022] [Accepted: 06/01/2023] [Indexed: 07/28/2023]
Abstract
BACKGROUND Darier's disease (DD) is a genodermatosis caused by mutations of the ATP2A2 gene leading to disrupted keratinocyte adhesion. Recurrent episodes of skin inflammation and infections with a typical malodour in DD indicate a role for microbial dysbiosis. Here, for the first time, we investigated the DD skin microbiome using a metabarcoding approach of 115 skin swabs from 14 patients and 14 healthy volunteers. Furthermore, we analyzed its changes in the context of DD malodour and the cutaneous DD transcriptome. RESULTS We identified a disease-specific cutaneous microbiome with a loss of microbial diversity and of potentially beneficial commensals. Expansion of inflammation-associated microbes such as Staphylococcus aureus and Staphylococcus warneri strongly correlated with disease severity. DD dysbiosis was further characterized by abundant species belonging to Corynebacteria, Staphylococci and Streptococci groups displaying strong associations with malodour intensity. Transcriptome analyses showed marked upregulation of epidermal repair, inflammatory and immune defence pathways reflecting epithelial and immune response mechanisms to DD dysbiotic microbiome. In contrast, barrier genes including claudin-4 and cadherin-4 were downregulated. CONCLUSIONS These findings allow a better understanding of Darier exacerbations, highlighting the role of cutaneous dysbiosis in DD inflammation and associated malodour. Our data also suggest potential biomarkers and targets of intervention for DD. Video Abstract.
Collapse
Affiliation(s)
- Yacine Amar
- Department of Dermatology and Allergy, Technical University of Munich, School of Medicine, Munich, Germany
| | - Danielle Rogner
- Department of Dermatology and Allergy, Technical University of Munich, School of Medicine, Munich, Germany
| | - Rafaela L Silva
- Department of Dermatology and Allergy, Technical University of Munich, School of Medicine, Munich, Germany
| | - Bärbel U Foesel
- Research Unit Comparative Microbiome Analysis, Helmholtz Zentrum München, Deutsches Forschungszentrum Für Gesundheit Und Umwelt (GmbH), 85764, Neuherberg, Germany
| | - Minhaz Ud-Dean
- Institute of Computational Biology, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764, Neuherberg, Germany
- Department of Informatics, Technical University of Munich, Garching, Germany
| | - Ilias Lagkouvardos
- Core Facility Microbiome, Technical University of Munich, 85354, Freising, Germany
| | - Susanne A Steimle-Grauer
- Department of Dermatology and Allergy, Technical University of Munich, School of Medicine, Munich, Germany
| | - Sebastian Niedermeier
- Department of Dermatology and Allergy, Technical University of Munich, School of Medicine, Munich, Germany
| | - Susanne Kublik
- Research Unit Comparative Microbiome Analysis, Helmholtz Zentrum München, Deutsches Forschungszentrum Für Gesundheit Und Umwelt (GmbH), 85764, Neuherberg, Germany
| | - Manja Jargosch
- Department of Dermatology and Allergy, Technical University of Munich, School of Medicine, Munich, Germany
| | - Matthias Heinig
- Institute of Computational Biology, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764, Neuherberg, Germany
- Department of Informatics, Technical University of Munich, Garching, Germany
| | - Jenny Thomas
- Center of Allergy & Environment (ZAUM), Technical University of Munich (TUM) and Helmholtz Zentrum München, German Research Center for Environmental Health, Member of the German Center of Lung Research (DZL), Munich, Germany
| | - Stefanie Eyerich
- Center of Allergy & Environment (ZAUM), Technical University of Munich (TUM) and Helmholtz Zentrum München, German Research Center for Environmental Health, Member of the German Center of Lung Research (DZL), Munich, Germany
| | - Jakob D Wikström
- Dermatology and Venereology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
- Dermato-Venereology Clinic, Karolinska University Hospital, Stockholm, Sweden
| | - Michael Schloter
- Research Unit Comparative Microbiome Analysis, Helmholtz Zentrum München, Deutsches Forschungszentrum Für Gesundheit Und Umwelt (GmbH), 85764, Neuherberg, Germany
| | - Kilian Eyerich
- Dermatology and Venereology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
- Department of Dermatology and Venereology, Medical Center, University of Freiburg, Freiburg, Germany
| | - Tilo Biedermann
- Department of Dermatology and Allergy, Technical University of Munich, School of Medicine, Munich, Germany.
| | - Martin Köberle
- Department of Dermatology and Allergy, Technical University of Munich, School of Medicine, Munich, Germany
| |
Collapse
|
2
|
Pastukhova E, LaBerge L. Segmental Darier’s disease: A case report. SAGE Open Med Case Rep 2023; 11:2050313X231160938. [PMID: 37032996 PMCID: PMC10074609 DOI: 10.1177/2050313x231160938] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/07/2023] Open
Abstract
Segmental Darier’s disease is an uncommon subtype of Darier’s genodermatosis, resulting
from a mutation in the ATPase type 2 during early embryogenesis. It typically presents as
a persistent, pruritic papular eruption following the lines of Blaschko. Histopathology of
Darier’s disease demonstrates acantholysis, dyskeratosis, and corps ronds. First-line
treatment includes topical retinoids, calcineurin inhibitors, and synthetic vitamin D
analogues. Severe disease may require systemic therapy with oral retinoids,
immunomodulators, magnesium, and low-dose naltrexone. Segmental Darier’s disease is
important to recognize both clinically and histologically as it may resemble other
acantholytic Blaschkolinear dermatoses and should be considered in individuals presenting
with a chronic localized papular eruption in a Blaschkoid distribution. Herein, we present
a case of a 48-year-old male with segmental Darier’s disease who improved significantly
following acitretin treatment.
Collapse
Affiliation(s)
| | - Lauren LaBerge
- Faculty of Medicine, University of Ottawa,
Ottawa, ON, Canada
- Division of Dermatology, The Ottawa Hospital,
University of Ottawa, Ottawa, ON, Canada
- Lauren LaBerge, Division of Dermatology, The Ottawa
Hospital, University of Ottawa, 4th Floor, 737 Parkdale Avenue, Ottawa, ON K1Y 1J8,
Canada.
| |
Collapse
|
3
|
Rogner DF, Lammer J, Zink A, Hamm H. Morbus Darier und Morbus Hailey‐Hailey: Stand 2021. J Dtsch Dermatol Ges 2021; 19:1478-1502. [PMID: 34661362 DOI: 10.1111/ddg.14619_g] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2021] [Accepted: 07/28/2021] [Indexed: 01/19/2023]
Affiliation(s)
- Danielle Franziska Rogner
- Klinik und Poliklinik für Dermatologie und Allergologie, Klinikum Rechts der Isar, Technische Universität München
| | - Judith Lammer
- Klinik und Poliklinik für Dermatologie und Allergologie, Klinikum Rechts der Isar, Technische Universität München
| | - Alexander Zink
- Klinik und Poliklinik für Dermatologie und Allergologie, Klinikum Rechts der Isar, Technische Universität München
| | - Henning Hamm
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Würzburg
| |
Collapse
|
4
|
Rogner DF, Lammer J, Zink A, Hamm H. Darier and Hailey-Hailey disease: update 2021. J Dtsch Dermatol Ges 2021; 19:1478-1501. [PMID: 34661345 DOI: 10.1111/ddg.14619] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2021] [Accepted: 07/28/2021] [Indexed: 01/16/2023]
Abstract
The autosomal-dominant genodermatoses Darier disease and Hailey-Hailey disease present special challenges to dermatologists. Despite their similar pathogenesis featuring impaired adhesion of suprabasal keratinocytes as a result of defective ATPases in epidermal calcium channels, the two diseases differ considerably in clinical presentation and therapeutic options. Darier disease is characterized by reddish brown, keratotic papules in seborrheic and intertriginous areas, which may coalesce into extensive lesions. Individuals affected with Hailey-Hailey disease primarily develop intertriginous papulovesicles and small blisters, which often evolve into erythematous plaques with erosions and painful fissures. Quality of life is significantly reduced because of complaints (itch, burning sensation, pain), body malodor and chronicity. Therapeutic options remain limited. Antiseptics and intermittent topical corticosteroids are a cornerstone of therapy, and systemic anti-infective treatment is often required in cases of superinfection. Ablative surgical interventions such as dermabrasion and CO2 laser surgery can lead to long-term remissions in intertriginous Hailey-Hailey disease, while temporary relief may also be achieved by intralesional injections of botulinum toxin. Of the systemic medications available for Darier disease, acitretin, which is approved for this purpose, has the best supporting evidence. The efficacy of immunosuppressants and immune modulators is inconsistent. Low-dose naltrexone produces more satisfactory results in Hailey-Hailey than Darier disease. The present CME article summarizes current knowledge of the two dermatoses, taking recent developments into account.
Collapse
Affiliation(s)
- Danielle Franziska Rogner
- Hospital and Clinic for Dermatology and Allergology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany
| | - Judith Lammer
- Hospital and Clinic for Dermatology and Allergology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany
| | - Alexander Zink
- Hospital and Clinic for Dermatology and Allergology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany
| | - Henning Hamm
- Department of Dermatology, Venereology and Allergology, University Würzburg, Würzburg, Germany
| |
Collapse
|
5
|
Yeshurun A, Ziv M, Cohen-Barak E, Vered S, Rozenman D, Sah M, Khayat M, Polyakov O, Amichai B, Zlotogorski A, Shalev S, Dodiuk-Gad RP. An Update on the Cutaneous Manifestations of Darier Disease. J Cutan Med Surg 2021; 25:498-503. [PMID: 33715454 DOI: 10.1177/1203475421999331] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND Knowledge about the clinical features of Darier disease, an orphan autosomal-dominant genetic disorder, is sparse and has been evaluated only in few studies. OBJECTIVES To investigate the clinical features of a large group of patients with Darier disease, and to explore for associations between disease characteristics and severity of the disease. METHODS Seventy-six individuals with Darier disease were evaluated utilizing a structured questionnaire-based interview, a physical examination, and a retrospective assessment of their medical records. RESULTS The most frequent locations of lesions were hands (99%) and fingernails (93%). Wart-like lesions on the hands were more visible after soaking them in water for 5 minutes, we therefore named this phenomenon the "wet hand sign". Oral involvement was found in 43% of patients, while 48% of women and 16% of men showed genital lesions. Patients with severe Darier disease had a tenfold greater risk of developing genital lesions than those with mild disease (P = .01). Most patients (88%) in our study exhibited a combination of the four types of the disease patterns of distribution (flexural, seborrheic, nevoid, and acral). CONCLUSIONS Documentation of disease on the hands and fingernails provides a highly sensitive means to aid in the diagnosis of Darier disease. It is important to evaluate mucosal lesions including genital and oral mucosa.
Collapse
Affiliation(s)
- Algit Yeshurun
- 26747 Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.,61172 Department of Dermatology, Emek Medical Center, Afula, Israel
| | - Michael Ziv
- 26747 Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.,61172 Department of Dermatology, Emek Medical Center, Afula, Israel
| | - Eran Cohen-Barak
- 26747 Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.,61172 Department of Dermatology, Emek Medical Center, Afula, Israel
| | - Shiraz Vered
- 26748 Department of Statistics, Haifa University, Haifa, Israel
| | - Dganit Rozenman
- 26747 Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.,61172 Department of Dermatology, Emek Medical Center, Afula, Israel
| | - Muhammad Sah
- 61172 Department of Dermatology, Emek Medical Center, Afula, Israel
| | - Morad Khayat
- Genetic Institute, Emek Medical Center, Afula, Israel
| | | | - Boaz Amichai
- 37253 Dermatology Unit, Meir Medical Center & Sackler Faculty of Medicine Tel-Aviv University
| | - Abraham Zlotogorski
- 58884 Department of Dermatology, Hadassah - Hebrew University Medical Center, Jerusalem, Israel
| | - Stavit Shalev
- 26747 Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.,Genetic Institute, Emek Medical Center, Afula, Israel
| | - Roni P Dodiuk-Gad
- 26747 Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.,61172 Department of Dermatology, Emek Medical Center, Afula, Israel.,Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
| |
Collapse
|
6
|
Dreyfus I, Maza A, Rodriguez L, Merlos M, Texier H, Rousseau V, Sommet A, Mazereeuw-Hautier J. Botulinum toxin injections as an effective treatment for patients with intertriginous Hailey-Hailey or Darier disease: an open-label 6-month pilot interventional study. Orphanet J Rare Dis 2021; 16:93. [PMID: 33602313 PMCID: PMC7893874 DOI: 10.1186/s13023-021-01710-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2020] [Accepted: 01/21/2021] [Indexed: 11/04/2022] Open
Abstract
BACKGROUND Patients with Hailey-Hailey and Darier diseases present with disabling inflammatory lesions located in large skin folds, which are often exacerbated or induced by sweating. Quality of life is highly impaired because of pain and recurrent skin infections. An improvement in skin lesions after botulinum toxin A injections has previously been reported in some patients but no prospective interventional studies are available. The aim of this open-label, 6-month, interventional pilot study (NCT02782702) was to evaluate the effectiveness and safety of botulinum toxin A for patients with moderate to very severe skin lesions located in folds. RESULTS Thirty patients (26 Hailey-Hailey/4 Darier) were included. Botulinum toxin A proved effective within the first month in two-thirds of patients, taking all study parameters (itchiness, cutaneous pain, sweating and odour, infections, psychosocial impairment and quality of life) into account and persisted during the 6-month follow-up period. No patient was classed as a BtxA non-responder, but 11 (37%) Hailey-Hailey patients (the most severe ones), experienced a relapse during the study. No serious side effects were reported. Mild transient clear fluid discharge at the site of the injections was reported for 27% of patients. CONCLUSIONS Botulinic toxin seems to be an effective and safe treatment for Hailey-Hailey and Darier diseases. Nevertheless, it may prove insufficient for the severest of Hailey-Hailey cases and could be considered as supplementary to other conventional treatments. Further studies are required to confirm our results on larger Darier cohorts.
Collapse
Affiliation(s)
- Isabelle Dreyfus
- Reference Centre for Rare Skin Diseases, Dermatology Department (CRMRP), Larrey University Hospital, 24, Chemin de Pouvourville TSA 30030, 31059, Toulouse, France.
| | - Aude Maza
- Reference Centre for Rare Skin Diseases, Dermatology Department (CRMRP), Larrey University Hospital, 24, Chemin de Pouvourville TSA 30030, 31059, Toulouse, France
| | - Lauriane Rodriguez
- Reference Centre for Rare Skin Diseases, Dermatology Department (CRMRP), Larrey University Hospital, 24, Chemin de Pouvourville TSA 30030, 31059, Toulouse, France
| | - Margot Merlos
- Reference Centre for Rare Skin Diseases, Dermatology Department (CRMRP), Larrey University Hospital, 24, Chemin de Pouvourville TSA 30030, 31059, Toulouse, France
| | - Hélène Texier
- Reference Centre for Rare Skin Diseases, Dermatology Department (CRMRP), Larrey University Hospital, 24, Chemin de Pouvourville TSA 30030, 31059, Toulouse, France
| | - Vanessa Rousseau
- Department of Clinical Pharmacology, CIC1436, University Hospital, Toulouse, France
| | - Agnès Sommet
- Department of Clinical Pharmacology, CIC1436, University Hospital, Toulouse, France
| | - Juliette Mazereeuw-Hautier
- Reference Centre for Rare Skin Diseases, Dermatology Department (CRMRP), Larrey University Hospital, 24, Chemin de Pouvourville TSA 30030, 31059, Toulouse, France.,Paul Sabatier University, Toulouse, France
| |
Collapse
|
7
|
Frew JW, Davidson M, Murrell DF. Disease-specific health related quality of life patient reported outcome measures in Genodermatoses: a systematic review and critical evaluation. Orphanet J Rare Dis 2017; 12:189. [PMID: 29284525 PMCID: PMC5747090 DOI: 10.1186/s13023-017-0739-5] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2017] [Accepted: 12/07/2017] [Indexed: 12/30/2022] Open
Abstract
Background Health Related Quality of Life (HR-QoL) Patient reported outcome measures (PROMs) have high utility in evaluation of new interventions in genodermatoses, however inconsistent standards of development and validation have hampered widespread acceptance and adoption. Objectives To identify all published HR-QoL PROMs in genodermatoses and critically evaluate their development and measurement properties. Methods This systematic review was registered with PROSPERO (CRD42016053301). Ovid Medline, Embase and PsycINFO databases were utilised for literature review using predefined inclusion and exclusion criteria. PROM development was assessed using the COSMIN Checklist and measurement properties were assessed against quality criteria for measurement properties of health standard questionnaires. Results 15 HRQoL PROMs in genodermatoses were identified. Major areas of deficiency in development were internal consistency, reliability and structural validity. No PROM satisfied measurement property standards for agreement, responsiveness or floor and ceiling effects. Four PROMs included Minimal Important Change scores for interpretability. Issues regarding the generalisability of the evaluated PROMs in culturally diverse and paediatric populations remain unresolved. Conclusions The overall standards of development and measurement properties in PROMs in genodermatoses is fair, despite no single instrument meeting all requirements. None are perfectly validated according to COSMIN criteria but seven of the fifteen PROMs may be appropriate pending further validation. The development of culturally appropriate and child-specific variants of PROMs should be a priority in order to increase the utility of patient based outcome measures in genodermatoses in various patient populations. Electronic supplementary material The online version of this article (10.1186/s13023-017-0739-5) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- John W Frew
- Department of Dermatology, Liverpool Hospital, Sydney, Australia. .,Faculty of Medicine, UNSW, Sydney, Australia.
| | | | - Dedee F Murrell
- Faculty of Medicine, UNSW, Sydney, Australia.,Department of Dermatology St George Hospital, Sydney, Australia
| |
Collapse
|
8
|
Nellen RGL, Steijlen PM, van Steensel MAM, Vreeburg M, Frank J, van Geel M. Mendelian Disorders of Cornification Caused by Defects in Intracellular Calcium Pumps: Mutation Update and Database for Variants in ATP2A2 and ATP2C1 Associated with Darier Disease and Hailey-Hailey Disease. Hum Mutat 2017; 38:343-356. [PMID: 28035777 DOI: 10.1002/humu.23164] [Citation(s) in RCA: 40] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2016] [Revised: 10/30/2016] [Accepted: 12/26/2016] [Indexed: 12/22/2022]
Abstract
The two disorders of cornification associated with mutations in genes coding for intracellular calcium pumps are Darier disease (DD) and Hailey-Hailey disease (HHD). DD is caused by mutations in the ATP2A2 gene, whereas the ATP2C1 gene is associated with HHD. Both are inherited as autosomal-dominant traits. DD is mainly defined by warty papules in seborrheic and flexural areas, whereas the major symptoms of HHD are vesicles and erosions in flexural skin. Both phenotypes are highly variable. In 12%-40% of DD patients and 12%-55% of HHD patients, no mutations in ATP2A2 or ATP2C1 are found. We provide a comprehensive review of clinical variability in DD and HHD and a review of all reported mutations in ATP2A2 and ATP2C1. Having the entire spectrum of ATP2A2 and ATP2C1 variants allows us to address the question of a genotype-phenotype correlation, which has not been settled unequivocally in DD and HHD. We created a database for all mutations in ATP2A2 and ATP2C1 using the Leiden Open Variation Database (LOVD v3.0), for variants reported in the literature and future inclusions. This data may be of use as a reference tool in further research on treatment of DD and HHD.
Collapse
Affiliation(s)
- Ruud G L Nellen
- Departments of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands.,GROW Research School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands
| | - Peter M Steijlen
- Departments of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands.,GROW Research School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands
| | - Maurice A M van Steensel
- Departments of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands.,GROW Research School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.,Clinical Genetics, Maastricht University Medical Centre, Maastricht, The Netherlands
| | - Maaike Vreeburg
- Clinical Genetics, Maastricht University Medical Centre, Maastricht, The Netherlands
| | -
- Departments of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands
| | - Jorge Frank
- Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany
| | - Michel van Geel
- Departments of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands.,GROW Research School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.,Clinical Genetics, Maastricht University Medical Centre, Maastricht, The Netherlands
| |
Collapse
|
9
|
Dodiuk-Gad R, Cohen-Barak E, Khayat M, Milo H, Amariglio-Diskin L, Danial-Faran N, Sah M, Ziv M, Shani-Adir A, Amichai B, Zlotogorski A, Borochowitz Z, Rozenman D, Shalev S. Darier disease in Israel: combined evaluation of genetic and neuropsychiatric aspects. Br J Dermatol 2015; 174:562-8. [DOI: 10.1111/bjd.14220] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/05/2015] [Indexed: 11/30/2022]
Affiliation(s)
- R.P. Dodiuk-Gad
- Department of Dermatology; Haemek Medical Center; Afula Israel
- Division of Dermatology; Department of Medicine; Sunnybrook Health Sciences Centre; University of Toronto; Toronto ON Canada
- The Rappaport Faculty of Medicine; Technion; Haifa Israel
| | - E. Cohen-Barak
- Department of Dermatology; Haemek Medical Center; Afula Israel
- The Rappaport Faculty of Medicine; Technion; Haifa Israel
| | - M. Khayat
- The Rappaport Faculty of Medicine; Technion; Haifa Israel
- Genetic Institute; Haemek Medical Center; Afula Israel
| | - H. Milo
- Genetic Institute; Haemek Medical Center; Afula Israel
| | | | - N. Danial-Faran
- The Rappaport Faculty of Medicine; Technion; Haifa Israel
- Genetic Institute; Haemek Medical Center; Afula Israel
| | - M. Sah
- Department of Dermatology; Haemek Medical Center; Afula Israel
- The Rappaport Faculty of Medicine; Technion; Haifa Israel
| | - M. Ziv
- Department of Dermatology; Haemek Medical Center; Afula Israel
- The Rappaport Faculty of Medicine; Technion; Haifa Israel
| | - A. Shani-Adir
- Department of Dermatology; Haemek Medical Center; Afula Israel
- The Rappaport Faculty of Medicine; Technion; Haifa Israel
| | - B. Amichai
- Department of Dermatology; Sheba Medical Center; Tel-Hashomer Israel
| | - A. Zlotogorski
- Department of Dermatology; Hadassah - Hebrew University Medical Center; Jerusalem Israel
| | - Z. Borochowitz
- The Rappaport Faculty of Medicine; Technion; Haifa Israel
- The Simon Winter Institute for Human Genetics; Bnei-Zion Medical Center; Haifa Israel
| | - D. Rozenman
- Department of Dermatology; Haemek Medical Center; Afula Israel
- The Rappaport Faculty of Medicine; Technion; Haifa Israel
| | - S. Shalev
- The Rappaport Faculty of Medicine; Technion; Haifa Israel
- Genetic Institute; Haemek Medical Center; Afula Israel
| |
Collapse
|
10
|
Raszewska-Famielec M, Dudra-Jastrzębska M, Borzęcki A, Chodorowskaf G. Darier-White disease treated with fractional CO2laser in two cases. Dermatol Ther 2015; 28:254-7. [DOI: 10.1111/dth.12226] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- Magdalena Raszewska-Famielec
- NZOZ Med-Laser Clinic; Medical University; Lublin Poland
- Departments of Dermatology and Venerology; Medical University; Lublin Poland
| | - Monika Dudra-Jastrzębska
- NZOZ Med-Laser Clinic; Medical University; Lublin Poland
- Departments of Pathophysiology; Medical University; Lublin Poland
| | - Adam Borzęcki
- NZOZ Med-Laser Clinic; Medical University; Lublin Poland
| | | |
Collapse
|
11
|
Shalom G, Kahn E, Halevy S. A severe fatal case of Darier-White disease-an extreme phenotype or a new entity? JAAD Case Rep 2015; 1:41-3. [PMID: 27051677 PMCID: PMC4802534 DOI: 10.1016/j.jdcr.2014.11.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Affiliation(s)
- Guy Shalom
- Department of Dermatology and Venereology, Soroka Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
| | - Elena Kahn
- Department of Pathology, Soroka Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
| | - Sima Halevy
- Department of Dermatology and Venereology, Soroka Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
| |
Collapse
|